You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Corrections to: Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature

Article Text

Article menu

This article has a correction. Please see:

Download PDFPDF

XML
Correction
Corrections to: Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature
  1. Noha Abdel-Wahab1,2,
  2. Houssein Safa3,
  3. Ala Abudayyeh4,
  4. Daniel H. Johnson3,
  5. Van Anh Trinh3,
  6. Chrystia M. Zobniw3,
  7. Heather Lin5,
  8. Michael K. Wong3,
  9. Maen Abdelrahim6,
  10. A. Osama Gaber6,
  11. Maria E. Suarez-Almazor1 and
  12. Adi Diab3,l
  1. Aff1 0000 0001 2291 4776grid.240145.6Section of Rheumatology and Clinical Immunology, Department of General Internal MedicineThe University of Texas MD Anderson Cancer Center Houston TX USA
  2. Aff2 0000 0004 0621 6144grid.411437.4Department of Rheumatology and Rehabilitation, Faculty of MedicineAssiut University Hospitals Assiut Egypt
  3. Aff3 0000 0001 2291 4776grid.240145.6Department of Melanoma Medical OncologyThe University of Texas MD Anderson Cancer Center Houston TX USA
  4. Aff4 0000 0001 2291 4776grid.240145.6Section of Nephrology, Division of Internal MedicineThe University of Texas MD Anderson Cancer Center Houston TX USA
  5. Aff5 0000 0001 2291 4776grid.240145.6Department of BiostatisticsThe University of Texas MD Anderson Cancer Center Houston TX USA
  6. Aff6 0000 0004 0445 0041grid.63368.38Houston Methodist Hospital Houston TX USA
  1. ↵l adiab{at}mdanderson.org

Abstract

Following publication of the original article [1], the authors reported an error in the Acknowledgments section. It should be read: ‘We are grateful to Mohsin Shah from the Department of Emergency Medicine at The University of Texas MD Anderson Cancer Center for assisting in study selection, and to Gregory F. Pratt from the Research Medical Library and Erica Goodoff, from the Department of Scientific Publications at The University of Texas MD Anderson Cancer Center for their valuable contributions.

Maria E. Suarez-Almazor and Adi Diab contributed equally to this work.

The original article can be found online at 10.1186/s40425-019-0585-1

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

https://doi.org/10.1186/s40425-019-0639-4

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Maria E. Suarez-Almazor and Adi Diab contributed equally to this work.

    The original article can be found online at 10.1186/s40425-019-0585-1

    Correction to: J Immunother Cancer (2019) 7:106

    https://doi.org/10.1186/s40425-019-0585-1

    Following publication of the original article [1], the authors reported an error in the Acknowledgments section. It should be read: ‘We are grateful to Mohsin Shah from the Department of Emergency Medicine at The University of Texas MD Anderson Cancer Center for assisting in study selection, and to Gregory F. Pratt from the Research Medical Library and Erica Goodoff, from the Department of Scientific Publications at The University of Texas MD Anderson Cancer Center for their valuable contributions.

    Reference

    1. 1.↵
      2. Abdel-Wahab N , et al
      . Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature. J Immunother Cancer. 2019;7:106 doi:10.1186/s40425-019-0585-1 pmcid:6469201
      OpenUrlAbstract/FREE Full Text